Results 201 to 210 of about 29,707 (225)
Some of the next articles are maybe not open access.
Avacopan for the Treatment of ANCA-Associated Vasculitis
New England Journal of Medicine, 2021David R Jayne +2 more
exaly
Zeitschrift fur Rheumatologie, 2014
Granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis belong to the anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitides (AAV). They share the feature of vasculitic manifestations in small to medium-size vessel beds which can occur in nearly any organ system.
openaire +2 more sources
Granulomatosis with polyangiitis, microscopic polyangiitis and eosinophilic granulomatosis with polyangiitis belong to the anti-neutrophil cytoplasmic antibodies (ANCA) associated vasculitides (AAV). They share the feature of vasculitic manifestations in small to medium-size vessel beds which can occur in nearly any organ system.
openaire +2 more sources
Genetics of ANCA-associated vasculitis: role in pathogenesis, classification and management
Nature Reviews Rheumatology, 2022Giorgio Trivioli +2 more
exaly
Plasma Exchange and Glucocorticoids in Severe ANCA-Associated Vasculitis
New England Journal of Medicine, 2020Michael Walsh +2 more
exaly
The Journal of scientific articles Health and Education millennium, 2018
E.O. Kazachkina +3 more
openaire +1 more source
E.O. Kazachkina +3 more
openaire +1 more source
Rituximab versus Cyclophosphamide for ANCA-Associated Vasculitis
New England Journal of Medicine, 2010John H Stone +2 more
exaly
Immunosuppression in ANCA-associated vasculitis
Transplantation Proceedings, 2001F J, van der Woude +6 more
openaire +2 more sources
Genetically Distinct Subsets within ANCA-Associated Vasculitis
New England Journal of Medicine, 2012Paul A Lyons +2 more
exaly
Rituximab versus Cyclophosphamide in ANCA-Associated Renal Vasculitis
New England Journal of Medicine, 2010Rachel B Jones +2 more
exaly